Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.60692/26fqm-mbk47
Publication URI: https://gresis.osc.int//doi/10.60692/26fqm-mbk47
Type: Other